BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 3029830)

  • 1. [False-positive findings of 67-gallium scintigraphy in staging/restaging of malignant lymphoma].
    Bihl H; Kimmig B
    Rofo; 1987 Feb; 146(2):172-7. PubMed ID: 3029830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of radiogallium in the staging and follow-up of lymphomas].
    Palumbo R
    Radiol Med; 1980 Oct; 66(10):746-8. PubMed ID: 6939031
    [No Abstract]   [Full Text] [Related]  

  • 3. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
    Zollars LE; Nagel JS; Tumeh SS
    J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
    Waxman AD; Eller D; Ashook G; Ramanna L; Brachman M; Heifetz L; McAndrews P; Bierman H; Taub R; Avedo M; Wall F
    J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of FDG-PET in malignant lymphoma.
    Becherer A; Jaeger U; Szabo M; Kletter K
    Q J Nucl Med; 2003 Mar; 47(1):14-21. PubMed ID: 12714950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallium-67-citrate scanning for the localization and staging of lymphomas.
    Adler S; Parthasarathy KL; Bakshi SP; Stutzman L
    J Nucl Med; 1975 Apr; 16(4):255-60. PubMed ID: 1089769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma.
    Mouratidis B; Gilday DL; Ash JM
    Nucl Med Commun; 1994 Mar; 15(3):144-7. PubMed ID: 8190402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallium-67 imaging in the management of Hodgkin's disease and other malignant lymphomas.
    Turner DA; Fordham EW; Ali A; Slayton RE
    Semin Nucl Med; 1978 Jul; 8(3):205-18. PubMed ID: 715464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
    Larcos G; Farlow DC; Antico VF; Gruenewald SM; Boyages J
    Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
    Setoain FJ; Pons F; Herranz R; Vidal-Sicart S; Lomeña F; Ayuso C; Montserrat E; Setoain J
    Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
    Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging and 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study.
    Bendini M; Zuiani C; Bazzocchi M; Dalpiaz G; Zaja F; Englaro E
    MAGMA; 1996; 4(3-4):213-24. PubMed ID: 9220410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallium-67 and technetium-99m-MDP scintigraphy for osseous involvement in lymphoma.
    Van de Wiele C; Dierckx RA; Simons M; Noens L
    J Nucl Med; 1996 Mar; 37(3):548. PubMed ID: 8772667
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gallium-67 imaging in the diagnosis of malignant lymphoma].
    Kubo A; Nakayama T; Shigematsu N; Kondoh M; Hashimoto S
    Rinsho Hoshasen; 1985 Oct; 30(11):1301-9. PubMed ID: 3910873
    [No Abstract]   [Full Text] [Related]  

  • 16. [SPECT-CT 67Ga studies in lymphoma disease. Contribution to staging and follow-up].
    Fuertes Manuel J; Estorch Cabrera M; Camacho Martí V; Flotats Giralt A; Rodríguez-Revuelto AA; Hernández Fructuoso MA; Carrió Gasset I
    Rev Esp Med Nucl; 2006; 25(4):242-9. PubMed ID: 16827987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical usefulness of 67Ga-citrate scintigraphy combined early image in malignant lymphoma--detection of abdominal lesions].
    Okazaki A; Katoh S; Noda M; Katsumata Y; Shirouzu I; Maehara T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Aug; 50(8):1007-15. PubMed ID: 2235335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
    Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
    J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical staging and diagnosis of malignant lymphoma].
    Niibe H; Tamaki Y; Akimoto T
    Gan No Rinsho; 1988 Apr; 34(5):541-54. PubMed ID: 3164415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of gallium-67 in malignant lymphoma.
    Makoski HB; Teske HJ; Becker G
    Acta Radiol Ther Phys Biol; 1976 Aug; 15(4):321-8. PubMed ID: 983781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.